Immunohistochemically, the tumor cells were positive for S100 protein, melan-A, and HMB-45, and negative for cytokeratins.[6] However, in our case study, the cancer cells were not immunoreactive against HMB-45 and Melan-A. The gene discussed is PMEL; the disease is neoplasm.